文献速递肿瘤 PET/CT放射性药物与辐射防护

全身PET扫描仪现状与未来展望

Hybrid total-body pet scanners-current status and future perspectives.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-10-14

本文通过文献调研总结当代全身(TB)PET/CT扫描仪的现状并展望未来发展。目前已有PennPET Explorer、uExplorer和Biograph Vision Quadra三款人体TB PET/CT系统,轴向视野(aFOV)达1至2米,系统灵敏度因更长机架而大幅提升。灵敏度提升为短期、低剂量、动态全身成像及几乎所有成像领域的新检查方法铺平道路。

要点

  • 三款人体TB PET/CT系统aFOV为1至2米,系统灵敏度大幅提升。
  • 灵敏度提升支持短期、低剂量、动态全身成像。
  • 新方法有望应用于几乎所有成像领域。

核心结论

  • 全身PET/CT系统灵敏度大幅提升,为短期、低剂量、动态全身成像及新检查方法创造条件。

研究设计与样本

  • 通过全面文献调研,总结当代全身PET/CT扫描仪现状并展望未来发展。

主要发现

  • 目前已开发三款人体TB PET/CT系统:PennPET Explorer、uExplorer和Biograph Vision Quadra。
  • 三款系统的轴向视野(aFOV)在1至2米之间。
  • 系统灵敏度因更长机架而大幅提升。

临床怎么用

  • 可利用提升的系统灵敏度开展短期、低剂量、动态全身PET成像。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose Since the 1990s, PET has been successfully combined with MR or CT systems. In the past years, especially PET systems have seen a trend towards an enlarged axial field of view (FOV), up to a factor of ten. Methods Conducting a thorough literature research, we summarize the status quo of contemporary total-body (TB) PET/CT scanners and give an outlook on possible future developments. Results Currently, three human TB PET/CT systems have been developed: The PennPET Explorer, the uExplorer, and the Biograph Vision Quadra realize aFOVs between 1 and 2 m and show a tremendous increase in system sensitivity related to their longer gantries. Conclusion The increased system sensitivity paves the way for short-term, low-dose, and dynamic TB imaging as well as new examination methods in almost all areas of imaging.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Nadig V, Herrmann K, Mottaghy FM, et al. Hybrid total-body pet scanners-current status and future perspectives. Eur J Nucl Med Mol Imaging. 2021. PMID: 34647154. doi:10.1007/s00259-021-05536-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。